The topics for the 5th IMI-2 Call are confirmed and the call is open
The topics for the 5th Call under the Innovative Medicines Initiative 2 are now confirmed, with a heavy emphasis on Alzheimer’s Disease (AD). The following four AD-related topics are included in the call:
– Inflammation and Alzheimer’s disease (AD): modulating microglia function – focussing on TREM2 and CD33
– Understanding the role of amyloid biomarkers in the current and future diagnosis and management of patients across the spectrum of cognitive impairment (from pre-dementia to dementia)
– Evolving models of patient engagement and access for earlier identification of Alzheimer’s disease: phased expansion study
– Apolipoprotein E (ApoE) biology to validated Alzheimer’s disease targets
The call is now open for stage 1 proposals with a deadline of October 13th, 2015. More information is available at the links below:
Links:
Call overview: http://www.imi.europa.eu/content/imi-2-call-5-0
Stage 1 proposals: http://www.imi.europa.eu/content/stage-1-16